Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids

Abstract

The prevalence of OIAI was 9%, with MME cumulative exposure being the only predictor for OIAI development. Patients on MME of 20 mg/day and above should be monitored for OIAI.